AR055029A1 - Uso de inhibidores de tirosina quinasa para el tratamiento de rinosinusitis cronica - Google Patents

Uso de inhibidores de tirosina quinasa para el tratamiento de rinosinusitis cronica

Info

Publication number
AR055029A1
AR055029A1 ARP060100386A ARP060100386A AR055029A1 AR 055029 A1 AR055029 A1 AR 055029A1 AR P060100386 A ARP060100386 A AR P060100386A AR P060100386 A ARP060100386 A AR P060100386A AR 055029 A1 AR055029 A1 AR 055029A1
Authority
AR
Argentina
Prior art keywords
treatment
kinase inhibitors
chronic rhinosinusitis
thyrosine kinase
thyrosine
Prior art date
Application number
ARP060100386A
Other languages
English (en)
Inventor
Birgit Jung
Bernd Disse
Gerald Pohl
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36228798&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR055029(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102005005505A external-priority patent/DE102005005505A1/de
Priority claimed from DE102005036216A external-priority patent/DE102005036216A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR055029A1 publication Critical patent/AR055029A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Abstract

Uso de inhibidores de EGFR quinasa, en especial de quinazolinas, quinolinas y pirimido-pirimidinas, para el tratamiento de poliposis nasal y rinosinusitis cronica.
ARP060100386A 2005-02-04 2006-02-03 Uso de inhibidores de tirosina quinasa para el tratamiento de rinosinusitis cronica AR055029A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005005505A DE102005005505A1 (de) 2005-02-04 2005-02-04 Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung der chronischen Rhinosinusitis
DE102005036216A DE102005036216A1 (de) 2005-08-02 2005-08-02 Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung der chronischen Rhinosinusitis

Publications (1)

Publication Number Publication Date
AR055029A1 true AR055029A1 (es) 2007-08-01

Family

ID=36228798

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060100386A AR055029A1 (es) 2005-02-04 2006-02-03 Uso de inhibidores de tirosina quinasa para el tratamiento de rinosinusitis cronica

Country Status (14)

Country Link
US (1) US20060178364A1 (es)
EP (1) EP1845992A1 (es)
JP (1) JP2009523700A (es)
KR (1) KR20070108889A (es)
AR (1) AR055029A1 (es)
AU (1) AU2006210175A1 (es)
BR (1) BRPI0607358A2 (es)
CA (1) CA2601740A1 (es)
EA (1) EA200701619A1 (es)
IL (1) IL184997A0 (es)
MX (1) MX2007009265A (es)
NO (1) NO20073097L (es)
TW (1) TW200638937A (es)
WO (1) WO2006082129A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009092052A2 (en) 2008-01-18 2009-07-23 Massachusetts Eye And Ear Infirmary Methods and compositions for treating polyps
EP2346507A1 (en) * 2008-09-03 2011-07-27 Boehringer Ingelheim International GmbH Use of quinazoline derivatives for the treatment of viral diseases
CN102264745B (zh) 2008-11-10 2015-07-22 财团法人卫生研究院 作为酪胺酸激酶抑制剂的稠合双环及多环嘧啶化合物
CN104844580B (zh) * 2015-04-17 2017-10-20 中国药科大学 嘧啶类化合物、其制备方法及医药用途
US20170007704A1 (en) * 2015-07-09 2017-01-12 David Ram Carrier and pharmaceutical compositions for intrasinal delivery and uses thereof
US11446302B2 (en) 2016-11-17 2022-09-20 Board Of Regents, The University Of Texas System Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations
RU2646806C1 (ru) * 2017-05-05 2018-03-07 Дмитрий Александрович Щербаков Способ лечения хронического полипозного риносинусита
KR20220057993A (ko) 2020-10-30 2022-05-09 오창민 코막힘, 콧물 등 알레르기 비염을 포함한 부비동 질환의 증상 개선을 위한 식품 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042062A1 (de) * 2000-08-26 2002-03-07 Boehringer Ingelheim Pharma Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Hertellung
DE10204462A1 (de) * 2002-02-05 2003-08-07 Boehringer Ingelheim Pharma Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
RS85404A (en) * 2002-03-30 2007-02-05 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., 4-(n-phenylamino)- quinazolines/quinolines as tyrosine kinase inhibitors
DE10334226A1 (de) * 2003-07-28 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
DE10350717A1 (de) * 2003-10-30 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse

Also Published As

Publication number Publication date
EP1845992A1 (de) 2007-10-24
MX2007009265A (es) 2007-09-07
KR20070108889A (ko) 2007-11-13
BRPI0607358A2 (pt) 2009-09-01
NO20073097L (no) 2007-07-12
IL184997A0 (en) 2007-12-03
TW200638937A (en) 2006-11-16
JP2009523700A (ja) 2009-06-25
AU2006210175A1 (en) 2006-08-10
EA200701619A1 (ru) 2008-02-28
US20060178364A1 (en) 2006-08-10
CA2601740A1 (en) 2006-08-10
WO2006082129A1 (de) 2006-08-10

Similar Documents

Publication Publication Date Title
AR055029A1 (es) Uso de inhibidores de tirosina quinasa para el tratamiento de rinosinusitis cronica
CL2008002097A1 (es) Compuestos derivados de heterociclos condensados sustituidos, inhibidores de cinasa de fosfatidil-inositol-3; composicion farmaceutica; y uso en el tratamiento del cancer.
CY1117546T1 (el) Eνωση διαμινο ετεροκυκλικου καρβοξαμιδιου
EA200870410A1 (ru) Антагонисты киназы
EA200970738A1 (ru) Ингибиторы активности akt
CL2011000191A1 (es) Compuestos derivados de pirimidina fusionada sustituida,inhibidores de mtor; composicion farmaceutica que lo comprende; y uso en el tratamiento del cancer.
CL2009000545A1 (es) Uso de un antagonista de c-met y un antagonista de her para el tratamiento de cancer.
CL2007002316A1 (es) Compuestos derivados de pirimidina, inhibidores de pi3k; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en enfermedades proliferativas como cancer.
CL2008001234A1 (es) Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer.
BRPI0810208A2 (pt) Combinação de terapias compreendendo inibidores p13k-alpha à base de quinoxalina para uso no tratamento do câncer.
DK1667991T3 (da) Quinazolinderivater som tyrosinkinaseinhibitorer
CL2008002243A1 (es) Compuestos derivados de 2-pirazolamino-1,3,5-triazina, inhibidores de kinasa jak; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento del cancer.
ATE432281T1 (de) Pyrrolotriazin-kinasehemmer
CL2011001536A1 (es) Compuestos derivados de pirimidin-2-il-1h-indol, inhibidores de la proteina quinasa atr; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de medicamentos utiles para el tratamiento del cancer.
CL2008001705A1 (es) Compuestos derivados de heterociclos de nitrogeno; y uso del compuesto para el tratamiento de enfermedades o trastornos relacionados con el receptor de histamina h3.
CL2008002369A1 (es) Compuestos derivados de piridin-3-il-oxipiridin-2-il-amino, inhibidores de alk5; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del cancer.
WO2008063558A3 (en) Combination of an inhibitor of dna polymerase-alpha and an inhibitor of a checkpoint kinase for proliferative disorders
WO2007129226A3 (en) Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
EA200801430A1 (ru) Производные триазола
NO20081292L (no) Pentasykliske kinaseinhibitorer
ATE520664T1 (de) Tyrosinkinase-hemmer
WO2007076320A3 (en) Compounds
ATE521603T1 (de) Chinazolinderivate als tyrosinkinaseinhibitoren
ATE414706T1 (de) Pyridopyrazolopyrimidinderivate und ihre anwendung gegen krebs und diabetes

Legal Events

Date Code Title Description
FB Suspension of granting procedure